ArticleFrontiers in public health2026
Colorectal cancer awareness and acceptance of fecal immunochemical test screening in Qassim, Saudi Arabia.
Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Colorectal cancer incidence in Saudi Arabia, 2002-2023: Age-specific trends and implications for screening and prevention.Preventive medicine reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Saudi Arabia recently launched a national colorectal cancer (CRC) screening program. Successful control of CRC depends not only on public acceptance but also on sustained adherence and adequate knowledge of CRC symptoms and risk factors. This study evaluated the acceptance, adherence, and knowledge of CRC in the Qassim region, and explored the barriers and facilitators of fecal immunochemical test (FIT) uptake. Methods: A cross-sectional survey of 2,050 average-risk adults aged 45-75 years was conducted at Qassim between December 2024 and February 2025. A structured questionnaire was used to collect socio-demographics, screening history, perceived barriers and facilitators, and knowledge of CRC symptoms and risk factors, utilizing a validated Cancer Awareness Measure (CAM). Logistic regression was used to identify predictors of FIT uptake. Results: Acceptance of FIT was high (88.3%), but adherence to annual testing was low (43.1%). Knowledge of CRC was poor (mean CAM score 8.2/22), and only 15.2% showed good knowledge. In the multivariable analysis, reduced uptake was independently associated with poorer self-perceived health (OR = 0.19, 95% CI 0.05-0.78) and low CRC knowledge (poor: OR = 0.34, 95% CI 0.16-0.73; intermediate: OR = 0.21, 95% CI 0.09-0.46), whereas more frequent physician visits (2-5/year: OR = 1.57, 95% CI 1.07-2.31; >5/year: OR = 6.07, 95% CI 1.84-19.99), prior screening (OR = 2.02, 95% CI 1.30-3.14) and previous FIT (OR = 6.50, 95% CI 3.61-11.69) predicted higher uptake. Misconceptions, fear, and logistical issues limited participation, while mailed kits, electronic results, and physician counseling encouraged uptake. Conclusion: In Qassim, FIT screening was widely accepted but poorly maintained, and CRC knowledge was low. National control of CRC will require accessible, patient-centered services and stronger public knowledge of symptoms and risk factors to support prevention, regular screening, and timely help-seeking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.